tert-Butyl 2-(6-ethoxypyridin-3-yl)pyrrolidine-1-carboxylate

Catalog No.: 
ACCESZ592
CAS No.: 
1352500-21-0
Molecular Formula: 
C16H24N2O3
Molecular Weight: 
292.38
tert-Butyl 2-(6-ethoxypyridin-3-yl)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$210.00InquiryInquiry
1g97%$642.00InquiryInquiry
5g97%$3146.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(6-ethoxypyridin-3-yl)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl 2-(6-ethoxypyridin-3-yl)pyrrolidine-1-carboxylate
Molecular FormulaC16H24N2O3
Molecular Weight292.38
SMILESO=C(N1C(C2=CC=C(OCC)N=C2)CCC1)OC(C)(C)C
InChI KeyWTAWEYHCVQSBJM-UHFFFAOYSA-N
Synonym2-(6-Ethoxy-pyridin-3-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester;1-Pyrrolidinecarboxylic acid, 2-(6-ethoxy-3-pyridinyl)-, 1,1-dimethylethyl ester
CAS No.1352500-21-0

Synthetic Route by SureRoute

1. ACCESZ592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIZRB936 route compound structure diagram
    ACIZRB9361352534-35-0In Stock
  2. Plus
  3. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  4. Then
  5. ACCESZ592 route product structure diagram
    ACCESZ5921352500-21-0
Inquiry

2. ACCESZ592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIZRB936 route compound structure diagram
    ACIZRB9361352534-35-0In Stock
  2. Plus
  3. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  4. Then
  5. ACCESZ592 route product structure diagram
    ACCESZ5921352500-21-0
Inquiry

3. ACCESZ592 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCESZ592 route product structure diagram
    ACCESZ5921352500-21-0
Inquiry

Comments (0)